Juniper Pharmaceuticals has extended its supply agreement for Crinone (progesterone gel) with an affiliate of Merck KGaA. The amended agreement extends the supply term an additional 4.5 years and at least through to December 31, 2024. The current term was due to expire in May 2020. Merck KGaA has marketing rights worldwide except the U.S., where Crinone is marketed by Allergan. “Our longstanding collaboration with Merck KGaA to supply Crinone progesterone gel for sale outside of the U.S...